Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-13

Clinical Trial Update: Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing therapeutic equivalence of Ketoconazole Cream 2% for tinea pedis has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketoconazole cream, 2% (ketoconazole)

Snippet

Sponsor: Encube Ethicals Pvt. Ltd. | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED | Results posted: 2019-06-13